Dr. Daniel J Renouf, MD
Claim this profileBC Cancer - Vancouver
Area of expertise
Pancreatic Cancer
Daniel J Renouf, MD has run 4 trials for Pancreatic Cancer. Some of their research focus areas include:
Breast Cancer
Daniel J Renouf, MD has run 2 trials for Breast Cancer. Some of their research focus areas include:
Affiliated Hospitals
BC Cancer - Vancouver
BC Cancer Agency
Clinical Trials Daniel J Renouf, MD is currently running
Genetic Testing
for Pancreatic Cancer
The goal of this study is to learn if the genetic information and proteins from tumours can help treat pancreatic ductal adenocarcinoma (PDAC). The main questions it aims to answer are: * Is it feasible to obtain genetic test results within a timeframe that can help inform treatment decisions for individuals with PDAC? * Can the genetic test results provide information about how a tumour will respond to or resist treatment? Participants will: * Receive standard chemotherapy to treat their cancer. * Provide samples of their blood, tissue, and fluid for genetic testing. * Visit the clinic every 4 weeks for check-ups and tests. * Complete questionnaires every 12 weeks.
Recruiting
1 award
N/A
4 criteria
Atezolizumab
for Cancer
This study will investigate the effects of atezolizumab on select cancer types in people whose analysis of tumour DNA and RNA indicates they may be sensitive to atezolizumab. This study aims to determine if the information from the cancer genome analysis corresponds with the effects of atezolizumab on individuals and their cancer. This is a Phase 2 study, which is undertaken after preliminary safety testing on a drug is completed, and will involve approximately 200 participants. Participants are assigned to one of 8 cohorts based on their primary tumour type: breast, lung, gastrointestinal (GI), primary unknown, genitourinary (GU), sarcoma, gynecological, and 'other' cancer types. Participants in all cohorts will receive the same dose of atezolizumab (1200 mg every 3 weeks). In the first stage for each cohort, 8 participants will be enrolled and if no participants respond to treatment, enrollment to that cohort will be closed. If 1 or more participants respond to treatment, up to 16 additional participants will be enrolled to that cohort. Participants continue on treatment until they no longer may benefit from the treatment or they decide to stop treatment.
Recruiting
1 award
Phase 2
10 criteria
More about Daniel J Renouf, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Daniel J Renouf, MD has experience with
- Tumour DNA And Proteins
- Anti-hyperglycemic Treatments (Metformin, Insulin, GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors)
- Continuous Glucose Monitor (CGM)
- CFI-402257
- BMS-986253
- Ipilimumab
Breakdown of trials Daniel J Renouf, MD has run
Pancreatic Cancer
High Blood Sugar
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel J Renouf, MD specialize in?
Daniel J Renouf, MD focuses on Pancreatic Cancer and Breast Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage III patients, or patients who are Stage IV.
Is Daniel J Renouf, MD currently recruiting for clinical trials?
Yes, Daniel J Renouf, MD is currently recruiting for 4 clinical trials in Vancouver British Columbia. If you're interested in participating, you should apply.
Are there any treatments that Daniel J Renouf, MD has studied deeply?
Yes, Daniel J Renouf, MD has studied treatments such as Tumour DNA and Proteins, Anti-hyperglycemic Treatments (Metformin, Insulin, GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors), Continuous Glucose Monitor (CGM).
What is the best way to schedule an appointment with Daniel J Renouf, MD?
Apply for one of the trials that Daniel J Renouf, MD is conducting.
What is the office address of Daniel J Renouf, MD?
The office of Daniel J Renouf, MD is located at: BC Cancer - Vancouver, Vancouver, British Columbia V5Z 4E6 Canada. This is the address for their practice at the BC Cancer - Vancouver.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.